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(5.5%) was statistically lower compared with
the appendectomy group (12.8%) (OR 0.42;
P ¼ 0.02).
However, when managing patients
with acute appendicitis nonoperatively, we
should keep in mind that the diagnosis of
appendicitis remains only a diagnosis of
probability. Indeed, although nowadays
patients are increasingly submitted to imag-
ing examinations, we must recognize that CT
scan might face with false-negative results
(complicated appendicitis finding after
appendectomy varies from 2.7% to 35% in
patients treated with antibiotics), and nega-
tive appendectomy rates are still estimated to
approach 8%.4–6
Similarly, conducting an analysis
of the incidence of surgical complica-
tions by comparing all patients who under-
went surgical therapy with appendectomy
to the entire population in the antibiotic-
first group, we found that this rate was
2.7% in the antibiotic group and 13.6%
in the appendectomy group (OR 0.22;
P < 0.0001).
The number and rates of postoperative
abscesses, surgical site infections, incisional
hernias, obstructive symptoms, and other
general complications (including adverse
reaction to antibiotics, anesthesiology com-
plications, cardiovascular, and pulmonary
adverse events) were analyzed on an inten-
tion-to-treat basis in our meta-analysis,
showing that the rate of complications of
antibiotic-first therapy was significantly
lower compared with appendectomy (7.1%
vs 14.5%; OR 0.41; P ¼ 0.006).
Whether the benefits of potentially
avoiding surgery with NOM are outweighed
by the burden to the patient related to future
episodes of appendicitis, the risk of persisting
abdominal discomfort, and the uncertainty
that may affect quality of life, remains an
unclear issue.7
This is especially true given that lap-
aroscopic appendectomy has a very favorable
safety profile, with a complication rate lower
than 10% in recent statistics, and typically
involves short hospitalization.
Probably, our meta-analysis, although
well designed and conducted with rigorous
statistical methods, represents a further step
nearer rather than a step toward the achieve-
ment of certainties on this debated issue.
What we can now say with certainty is that
for every 100 patients with uncomplicated
appendicitis, initial antibiotic therapy com-
pared with prompt appendectomy may
result in 91 fewer patients receiving surgery
during the first admission, and 20 more expe-
riencing recurrent appendicitis within the
first year.
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W ith great interest, we read Dr. Low’smulticenter paper1 aiming at defining
benchmarks on complications associated
with esophagectomy. We highly valuate this
manuscript that holds a large amount of
important information derived from a high-
quality prospective international database.
However, while benchmarking of
complex procedures is a novel tool to assess
outcome and to offer benchmark values for
comparisons with other cohorts of patients or
even single cases, the current work does not
fulfill the criteria of a true benchmark
analysis. The fundamental idea of bench-
marking is to provide a pragmatic and indi-
vidually accessible measure for quality that
allows for comparison with a best possible
outcome—the benchmark.2,3 Establishing a
valid benchmark involves several technical
steps,3 and it is essential that benchmarks
are generated from low-risk patient cohorts
using a standardized methodology.4,5 In
addition, it is critical to present benchmark
cut-off values for each outcome indicator
(usually the 75th percentile of each center’s
median to adjust for outcome variability
among centers).
In the present study, the authors did
not differentiate surgical approach or tech-
nique, nor did they provide different cut-off
values for a specific patient’s risk level.
Outcomes of patients with various comor-
bidity and different Americas Society of
Anesthesiologists scores that underwent all
types of (open or minimally invasive) esoph-
agectomy or with tumors located in the
proximal as well as distal esophagus, etc.,
are mixed together. Further, points of refer-
ence are presented as a percentage of all
patients included in the database, an
approach that does not compensate for
center-specific differences. For creating a
valid benchmark that truly serves as point
of reference of best possible outcome, the
surgical approach (minimally invasive,
hybrid, open, etc.) and the selection of
patients with low comorbidity, presumed
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to have the least amount of postoperative
complications, is of utter importance.5,6
Furthermore, results should be assessed for
each center individually and each hospital’s
median result (or percentage of binominal
outcomes) should be used for benchmark
value calculation. Therefore, the present
paper represents an excellent summary of
meticulously collected data but fails to pro-
vide reference values to assess performance
gaps for other groups of patients or variations
in surgical technique.
The authors report no conflicts of
interest.
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We read with great interest the recentarticle by Goldstein et al1 on A Road-
map for Aspiring Surgeon Scientists in
Today’s Healthcare Environment. In a col-
laborative effort with the Basic Science Com-
mittee of the Society of University Surgeons,
these authors lay a pathway for the surgeon
striving to develop a successful career as a
surgeon-scientist. This article builds on their
previous work, which identified barriers to
becoming a surgeon-scientist in the 21st cen-
tury. The authors are to be commended for
their contributions on such an important
issue.2
The surgeon-scientist has been
described as the ideal translational scientist,
capable of bridging the worlds of basic sci-
ence and clinical medicine to accelerate sur-
gical innovation and discovery.3 As the
authors point out, surgical history is rich with
stories of tremendous scientific advances that
transformed medicine and surgery. Despite
these achievements and the role surgeons-
scientists have played in shaping modern
healthcare, the number of surgeons pursuing
basic science has been on the decline.
Demanding clinical schedules in a labor-
intensive field, administrative duties, and
the adoption of productivity-based compen-
sation models has made it difficult for sur-
geons to balance productive clinical and
basic science careers.2 Moreover, personal
challenges including a lack of intrinsic inter-
est in basic science research, a desire for
work–life balance, and the desire to pay
off their mounting student loan debt have
discouraged many trainees from pursuing a
career as a surgeon-scientist.2,4 Collec-
tively, this has led to a dearth of surgeons
conducting bench work, which is concern-
ing given that many diseases are treated
primarily by surgeons. Certainly, this high-
lights the importance of training surgeons
in scientific methodology so that they can
answer important clinical questions that no
one outside of surgery can solve. This point
was recently emphasized in the journal
Nature, in which calls for surgeons to rein-
vigorate the pursuit of basic science were
made by nonsurgeons.5
We could not agree more with Gold-
stein et al that scientific training is para-
mount to the success of any surgeon-
scientist and their baseball analogy could
not be more valid. In order to take advantage
of the roadmap provided by the authors,
learning to conduct surgical science is of
the utmost importance. It is our belief that
the research fellowship is an invaluable tool
for learning this, and that the experience
gained during these formative years is instru-
mental in determining the future success of
the surgeon-scientist. At our institution, sur-
geon-scientists are trained under a National
Institutes of Health T32 training grant as part
of a mentored research fellowship. Through-
out the program, trainees receive guidance
from leading basic science and surgeon-
investigators. The pursuit of an advanced
degree (eg, Masters, PhD) in clinical and
translational science is required and includes
formal instruction in grant writing, protocol
development, biostatistics, bioethics, and
research electives designed to enhance the
trainees’ individualized goals. The training
experience is further augmented by simul-
taneously requiring trainees to spend 2 years
in National Institutes of Health-funded
laboratories engaged in cutting-edge basic
science research. We believe that this triple-
pronged approach puts the surgeon-scientist
trainee in the best position to bridge the gap
between basic science and the clinical world,
allowing them to go frombedside to bench and
back again in the name of surgical innovation.
The success of our trainees is evidenced by the
receipt of numerous research awards, extra-
mural grant funding, attainment of competi-
tive clinical fellowships, and publishing in
high impact surgical and scientific journals
including Nature. Equally important, our
trainees recognize that having a successful
career as a surgeon-scientist is both feasible
and rewarding.
The current lack of surgeon-scientists
pursuing basic science should be of great
concern to our field. The authors acknowl-
edge the many challenges and competing
interests facing surgical investigators. Yet,
for the sake of surgical innovation and patient
care, we must continue to aggressively pur-
sue basic investigation now more than ever.
Surgeon-scientist trainees should be taught
the value of conducting surgical research, and
that the tools gained will only add to their
armamentarium, allowing them to become
better surgeons and provide better care.6,7
The roadmap provided by Goldstein et al
provides a framework for aspiring surgeon-
scientists to follow. However, to successfully
navigate that roadmap, a surgeon must
also master the art of conducting surgical
science. We maintain that this endeavor
is best accomplished through mentored
research fellowships. As our healthcare
environment continues to evolve, so too
should our approach for recruiting and train-
ing the next generation of surgeon-scientists.
Surgeons who are well versed in basic as well
as clinical and translational science will be
poised to lead the next generation of surgical
innovation and discovery. Goldstein et al
should be commended for their important
contributions that promulgate avenues for
becoming a successful surgeon-scientist in
today’s healthcare environment.
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